Daniel Jackson, MD, recently received $50,000 from the American Academy of Allergy, Asthma and Immunology (AAAAI) as a recipient for the 2009 AAAAI GSK Fellows Career Development Award. This project will study the clinical severity and manifestations of Rhinovirus infections throughout childhood and early adolescents.